27 Apr 2018 29 Jun 2018 19 Jul 2018 Final Single Tier 20sen 27 Jun 2018 29 Apr 2019 04 Jul 2019 18 Jul 2019 Final Single Tier 22.35sen 03 Jul 2019 29 Sep 2020 15 Oct 2020 05 Nov 2020 Interim Single ...
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback